Tolerance and Pharmacokinetics of TQ-B3233
NCT03453034
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Tumor
Interventions
DRUG:
TQ-B3233
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.